Telomere-mediated mitotic disturbances in immortalized ovarian epithelial cells reproduce chromosomal and breakpoints from ovarian carcinoma

Genes Chromosomes and Cancer

Volumn 42, Issue 1, 2005, Pages 22-33

  Gisselsson, David ^a,b   Lv, Mei ^a   Tsao, Sai Wha ^c   Man, Cornelia ^a   Jin, Charlotte ^b   Höglund, Mattias ^b   Yok, Lam Kwong ^a   Jin, Yuesheng ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ANAPHASE; ARTICLE; CANCER CELL CULTURE; CANCER GRADING; CELL IMMORTALIZATION; CENTROMERE; CENTROSOME; CHROMOSOME LOSS; CONTROLLED STUDY; DNA SEQUENCE; EPITHELIUM CELL; FEMALE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; KARYOTYPE; MITOSIS; OVARY CARCINOMA; OVARY CELL; PRIORITY JOURNAL; TELOMERE; VIRUS GENE; WART VIRUS;

CELL CYCLE; CELL LINE, TUMOR; CHROMOSOME ABERRATIONS; CHROMOSOME DELETION; CHROMOSOMES, HUMAN; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; KARYOTYPING; MITOSIS; OVARIAN NEOPLASMS; TELOMERE;

PAPILLOMAVIRUS;

EID: 9644272618     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/gcc.20094     Document Type: Article

References (34)

1. Artandi SE, Chang S, Lee SL, Alson S, Gottlieb GJ, Chin L, DePinho RA. 2000. Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature 406:641-645.
2. Barnholtz-Sloan JS, Schwartz AG, Qureshi F, Jacques S, Malone J, Munkarah AR. 2003. Ovarian cancer: changes in patterns at diagnosis and relative survival over the last three decades. Am J Obstet Gynecol 189:1120-1127.
3. Bast RC Jr, Feeney M, Lazarus H, Nadler LM, Colvin RB, Knapp RC. 1981. Reactivity of a monoclonal antibody with human ovarian carcinoma. J Clin Invest 68:1331-1337.
4. Duensing S, Lee LY, Duensing A, Basile J, Piboonniyom S, Gonzalez S, Crum CP, Münger K. 2000. The human papillomavirus type 16 E6 and E7 oncoproteins cooperate to induce mitotic defects and genomic instability by uncoupling centrosome duplication from the cell division cycle. Proc Natl Acad Sci USA 97:10002-10007.
5. Duensing S, Munger K. 2002. The human papillomavirus type 16 E6 and E7 oncoproteins independently induce numerical and structural chromosome instability. Cancer Res 62:7075-7782.
6. Fogh J, Wright WC, Loveless JD. 1977. Absence of HeLa cell contamination in 169 cell lines derived from human tumors. J Natl Cancer Inst 58:209-214.
7. Ghadimi BM, Sackett DL, Difilippantonio MJ, Schröck E, Neumann T, Jauho A, Auer G, Ried T. 2000. Centrosome amplification and instability occurs exclusively in aneuploid, but not in diploid colorectal cancer cell lines, and correlates with numerical chromosomal aberrations. Genes Chromosomes Cancer 27:183-190.
8. Gisselsson D, Jonson T, Petersén Å, Strömbeck B, Dal Cin P, Höglund M, Mitelman F, Mertens F, Mandahl M. 2001. Telomere dysfunction triggers extensive DNA fragmentation and evolution of complex chromosome abnormalities in human malignant tumours. Proc Natl Acad Sci USA 98:12683-12688.
9. Gisselsson D, Jonson T, Yu C, Martins C, Jin Y, Wiegant J, Mandahl N, Mertens F, Jin C. 2002. Centrosome abnormalities, multipolar mitoses, and chromosomal instability in head and neck tumours with dysfunctional telomeres. Br J Cancer 87:202-207.
10. Hamilton TC, Young RC, McKoy WM, Grotzinger KR, Green JA, Chu EW, Whang-Peng J, Rogan AM, Green WR, Ozols RF. 1983. Characterization of a human ovarian carcinoma cell line (NIH: OVCAR-3) with androgen and estrogen receptors. Cancer Res 43:5379-5389.
11. Hastie ND, Dempster M, Dunlop MG, Thompson AM, Green DK, Allshire RC. 1990. Telomere reduction in human colorectal carcinoma and with ageing. Nature 346:866-868.
12. Havrilesky L, Darcy M, Hamdan H, Priore RL, Leon J, Bell J, Berchuck A. 2003. Prognostic significance of p53 mutation and p53 overexpression in advanced epithelial ovarian cancer: a Gynecologic Oncology Group study. J Clin Oncol 21:3814-3825.
13. Höglund M, Gisselsson D, Hansen GB, Säll T, Mitelman F. 2003. Ovarian carcinoma develops through multiple modes of chromosomal evolution. Cancer Res 63:3378-3385.
14. Jin Y, Zhang H, Tsao SW, Jin C, Lv M, Strömbeck B, Wiegant J, Wan TS, Yuen PW, Kwong YL. 2004. Cytogenetic and molecular genetic characterization of immortalized human ovarian surface epithelial cell lines: consistent loss of chromosome 13 and amplification of chromosome 20. Gynecol Oncol 92:183-191.
15. Karlseder J, Broccoli D, Dai Y, Hardy S, de Lange T. 1999. p53- and Atm-dependent apoptosis induced by telomeres lacking Trf2. Science 283:1321-1325.
16. Karlseder J, Smogorzewska A, de Lange T. 2002. Senescence induced by altered telomere state, not telomere loss. Science 295: 2446-2449.
17. Landsdorp PM, Verwoerd NP, van de Rijke FM, Dragowska W, Little M-T, Dirks RW, Raap AK, Tanke HJ. 1996. Heterogeneity of telomere length of human chromosomes. Hum Mol Genet 5:685-691.
18. Lengauer C, Kinzler KW, Vogelstein B. 1998. Genetic instabilities in human cancers. Nature 396:643-649.
19. Lingle WL, Barrett SL, Negron VC, D'Assoro AB, Boeneman K, Liu W, Whitehead CM, Reynolds C, Salisbury JL. 2002. Centrosome amplification drives chromosomal instability in breast tumor development. Proc Natl Acad Sci USA 99:1978-1983.
20. Litaker JR, Pan J, Cheung Y, Zhang DK, Liu Y, Wong SC, Wan TS, Tsao SW. 1998. Expression profile of senescence-associated beta-galactosidase and activation of telomerase in human ovarian surface epithelial cells undergoing immortalization. Int J Oncol 13: 951-956.
21. McClintock B. 1938. The production of homozygous deficient tissues with mutant characteristics by means of the aberrant behavior of ring-shaped chromosomes. Genetics 23:215-376.
22. Meraldi P, Honda R, Nigg EA. 2002. Aurora-A overexpression reveals tetraploidization as a major route to centrosome amplification in p53-/- cells. EMBO J 21:483-492.
23. Mertens F, Johansson B, Mitelman F. 1994. Isochromosomes in neoplasia. Genes Chromosomes Cancer 10:221-230.
24. Mitelman F, Johansson B, Mertens F. 2004. Mitelman Database of Chromosome Aberrations in Cancer. Available at: http://cgap. nci.nih.gov/Chromosomes/ Mitelman
25. Nigg EA. 2002. Centrosome aberrations: cause or consequence of cancer progression? Nat Rev Cancer 2:815-825.
26. Pejovic T, Heim S, Mandahl N, Baldetorp B, Elmfors B, Flodérus UM, Furgyik S, Helm G, Himmelmann A, Willén H, Mitelman F. 1992. Chromosome aberrations in 35 primary ovarian carcinomas. Genes Chromosomes Cancer 4:58-68.
27. Saunders WS, Shuster M, Huang X, Gharaibeh B, Enyenihi AH, Petersen I, Gollin SM. 2000. Chromosomal instability and cytoskeletal defects in oral cancer cells. Proc Natl Acad Sci USA 97:303-308.
28. Taetle R, Aickin M, Yang JM, Panda L, Emerson J, Roe D, Adair L, Thompson F, Liu Y, Wisner L, Davis JR, Trent J, Alberts DS. 1999. Chromosome abnormalities in ovarian adenocarcinoma: I. Nonrandom chromosome abnormalities from 244 cases. Genes Chromosomes Cancer 25:290-300.
29. Tanke HJ, Wiegant J, van Gijlswijk RP, Bezrookove V, Pattenier H, Heetebrij RJ, Talman EG, Raap AK, Vrolijk J. 1999. New strategy for multi-colour fluorescence in situ hybridisation: COBRA: COmbined Binary RAtio labelling. Eur J Hum Genet 7:2-11.
30. Tsao SW, Mok SC, Fey EG, Fletcher JA, Wan TS, Chew EC, Muto MG, Knapp RC, Berkowitz RS. 1995. Characterization of human ovarian surface epithelial cells immortalized by human papilloma viral oncogenes (HPV-E6E7 ORFs). Exp Cell Res 218:499-507.
31. Tsao SW, Wong N, Wang X, Liu Y, Wan TS, Fung LF, Lancaster WD, Gregoire L, Wong YC. 2001. Nonrandom chromosomal imbalances in human ovarian surface epithelial cells immortalized by HPV16-E6E7 viral oncogenes. Cancer Genet Cytogenet 130: 141-149.
32. Walen KH, Arnstein P. 1986. Induction of tumorigenesis and chromosomal abnormalities in human amniocytes infected with simian virus 40 and Kirsten sarcoma virus. In Vitro Cell Dev Biol 22:57-65.
33. Wu QJ, Guo M, Lu ZM, Li T, Qiao HZ, Ke Y. 2003. Detection of human papillomavirus-16 in ovarian malignancy. Br J Cancer 89:672-675.
34. Yang HJ, Liu VW, Tsang PC, Yip AM, Ng TY, Cheung AN, Ngan HY. 2003. Comparison of human papillomavirus DNA levels in gynecological cancers: implication for cancer development. Tumour Biol 24:310-316.